BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19667961)

  • 1. Urine proteomics biomarkers in renal transplantation: an overview.
    Quintana LF; Bañon-Maneus E; Solé-Gonzalez A; Campistol JM
    Transplantation; 2009 Aug; 88(3 Suppl):S45-9. PubMed ID: 19667961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells.
    Reinke P; Fietze E; Döcke WD; Kern F; Ewert R; Volk HD
    Transplantation; 1994 Jul; 58(1):35-41. PubMed ID: 7913561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol core biopsy as intermediate efficacy end-point in chronic kidney allograft rejection.
    Yilmaz S; Taskinen E; Häyry P; Isoniemi H
    Transplant Proc; 1996 Feb; 28(1):491-3. PubMed ID: 8644324
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive drug therapy and subclinical acute renal allograft rejection: impact and effect.
    Kuypers DR
    Transplantation; 2008 Apr; 85(7 Suppl):S25-30. PubMed ID: 18401259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection.
    Yannaraki M; Rebibou JM; Ducloux D; Saas P; Duperrier A; Felix S; Rifle G; Chalopin JM; Hervé P; Tiberghien P; Ferrand C
    Transpl Int; 2006 Sep; 19(9):759-68. PubMed ID: 16918537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a tool for noninvasive monitoring of renal allografts.
    Schaub S; Wilkins JA; Rush D; Nickerson P
    Expert Rev Proteomics; 2006 Oct; 3(5):497-509. PubMed ID: 17078764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary proteomics: a tool to discover biomarkers of kidney diseases.
    Dihazi H; Müller GA
    Expert Rev Proteomics; 2007 Feb; 4(1):39-50. PubMed ID: 17288514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary CD20 mRNA as a surrogate of CD20-positive cells infiltration during allograft dysfunction in renal transplant patients.
    Ponciano VC; Soares MF; Naka EL; Arruda EF; Cenedeze MA; Franco MF; Pacheco-Silva A; Câmara NO
    Int Immunopharmacol; 2009 Jun; 9(6):663-7. PubMed ID: 19111631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in renal transplantation.
    Bestard O; Cruzado JM; la Franquesa M; Grinyó JM
    Curr Opin Organ Transplant; 2010 Aug; 15(4):467-73. PubMed ID: 20613522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of chronic allograft rejection.
    Joosten SA; van Kooten C; Paul LC
    Transpl Int; 2003 Mar; 16(3):137-45. PubMed ID: 12664207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected prognostic factors of long-term renal graft function.
    Krejcí K
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():19-22. PubMed ID: 10743719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-dimensional difference gel electrophoresis urinary proteomic profile in the search of nonimmune chronic allograft dysfunction biomarkers.
    Bañón-Maneus E; Diekmann F; Carrascal M; Quintana LF; Moya-Rull D; Bescós M; Ramírez-Bajo MJ; Rovira J; Gutierrez-Dalmau A; Solé-González A; Abián J; Campistol JM
    Transplantation; 2010 Mar; 89(5):548-58. PubMed ID: 20134395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of allograft biopsy specimens in renal transplants with proteinuria: is proteinuria a culprit of graft loss?
    Kang CM; Kim GH; Lee CH; Kwak JY; Kwon OJ
    Transplant Proc; 2005 Mar; 37(2):984-6. PubMed ID: 15848598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of donor-derived DNA in serum: a new approach of acute rejection diagnosis in a rat kidney transplantation model.
    Martins PN; Mashreghi MF; Reutzel-Selke A; Neuhaus P; Volk HD; Tullius SG; Kotsch K
    Transplant Proc; 2005; 37(1):87-8. PubMed ID: 15808556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine proteomics in kidney transplantation.
    Kim SC; Page EK; Knechtle SJ
    Transplant Rev (Orlando); 2014 Jan; 28(1):15-20. PubMed ID: 24321302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors in chronic allograft nephropathy.
    Scolari MP; Cappuccilli ML; Lanci N; La Manna G; Comai G; Persici E; Todeschini P; Faenza A; Stefoni S
    Transplant Proc; 2005; 37(6):2482-4. PubMed ID: 16182717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG).
    Hauser IA; Spiegler S; Kiss E; Gauer S; Sichler O; Scheuermann EH; Ackermann H; Pfeilschifter JM; Geiger H; Gröne HJ; Radeke HH
    J Am Soc Nephrol; 2005 Jun; 16(6):1849-58. PubMed ID: 15857922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of urine sediment phenotyping in renal allograft recipients.
    Lao M; Wyzgał J; Nowaczyk M; Górski A
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):373-5. PubMed ID: 8010879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.